Moreover, the results elucidated that NR2F1-AS1 enhanced HCC progression via modulating the miR-642a/DEK axis, which strengthened understanding of HCC pathogenesis and the development of effective therapies. The gene discussed is DEK; the disease is hepatocellular carcinoma.